BNF:

Not listed

Status:

Grey

Decision Date:

August 2011

Comments

GREY: Patients must demonstrate they are an exception to current services provided for INR testing.

Grey Drug Classifications

• 5: Less cost-effective than current standard therapy
• 7: Not accepted as cost effective compared to other service development opportunities within the CCGs

search again